Kodak has been focused on the printing industry since coming out of bankrupt protection

 Kodak is moving into pharmaceutical manufacturing with  US government backing. Kodak will  be revamping it's facilities in Rochester and St Paul for the new  Pharmaceuticals operation, which will make ingredients for generic pharmaceuticals,  components  are  critical to the American people and US national security.

Some ingredients have been identified as essential “but have lapsed into chronic national shortage”. Kodak used to have a Health Imaging division but sold it in 2007. Kodak also  has reaffirmed its continuing commitment to the printing industry. Kodak’s share price rocketed  to from $7.94 to $13.32 – the 52-week high is $11.80.